Meaningful weight loss was seen with the use of semaglutide, regardless of whether people had previous weight loss surgery, a first-of-its-kind study revealed.
May 21, 2024 — Meaningful weight loss was seen with the weight loss drugs Wegovy or Ozempic regardless of whether people had previous weight loss surgery , a first-of-its-kind study reveals.
People in this study lost a lower percentage of their total body weight, compared to people in clinical trials for the drugs, who tended to lose up to 15%, said lead investigator Pourya Medhati, MD, a postdoctoral research fellow at Brigham and Women's Hospital in Boston. Total weight loss was not significantly different between men and women in the surgery group. But in the non-surgery group, women lost 6.4%, compared to 4.8% among men, a significant difference.
"Our study highlights the importance of addressing insurance to ensure broader access," Medhati said.
Obese Bariatric Surgery Obesity Surgery Weight Loss Surgery Weight Loss Weight Management Surgery Intestinal Surgery Gastrointestinal Surgery GI Surgery Practice Management Revenue Electronic Health Records Electronic Health Record EHR Patient Safety Insurance Adverse Effects Side Effects Hospitals Healthcare And Medical Technology Health And Medical Tech Health And Med Tech
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Semaglutide, gastric bypass delay weight loss plateau, study findsChloe Nordquist is a national journalist for the E.W. Scripps Company. She has a passion for telling community stories and giving a voice to the voiceless. Chloe has had the opportunity to report across the world, as far as Milan and Berlin. Previously she worked at news stations in California’s Central Valley and Southwest Florida.
Read more »
Beyond Weight Loss: Semaglutide Delivers Major Heart Health BenefitsScience, Space and Technology News 2024
Read more »
Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Ozempic Drug Semaglutide Could Cut Heart Risk By 20%—Regardless Of Weight Loss, Study FindsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Weight Loss Maintained With Slow Taper of SemaglutideA digital lifestyle program used in combination with semaglutide from low starting dose shows participants can maintain weight loss after tapering and stopping the drug, irrespective of starting BMI.
Read more »
Everything you need to know about semaglutide weight loss drugsThe semaglutide-based medicines Ozempic and Wegovy can help people who are obese or overweight to quickly lose weight, but questions remain over how long they should be taken and what other effects they may have
Read more »